FDA Cites Latisse Web Site For Implying Eyelash Growth Drug Is A Cosmetic
This article was originally published in The Rose Sheet
Executive Summary
Allergan's consumer Web site for its eyelash growth drug Latisse certainly caught FDA's eye, leading the agency to issue a Sept. 10 "untitled" letter that cautions against promoting a drug like a cosmetic